Clinical report - Health supervision for children with Prader-Willi syndrome

Pediatrics

Volumn 127, Issue 1, 2011, Pages 195-204

  McCandless, Shawn E ^a   Saal, Howard M ^a   Braddock, Stephen R ^a   Enns, Gregory ^a   Gruen, Jeffrey R ^a   Perrin, James M ^a   Saul, Robert A ^a   Tarini, Beth A ^a  

^a NONE

Author keywords

Genetic testing; Prader Labhart Willi syndrome; Prader Willi syndrome; Uniparental disomy

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN GROWTH HORMONE; HYDROCORTISONE;

ARTICLE; CHILD BEHAVIOR; CHILD CARE; CHILD GROWTH; CHILD NUTRITION; CHROMOSOME 15; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); CRYPTORCHISM; DNA METHYLATION; DNA SEQUENCE; EARLY DIAGNOSIS; FEEDING BEHAVIOR; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC PREDISPOSITION; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; NASOGASTRIC TUBE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROVOCATION TEST; STOMACH TUBE; WEIGHT CONTROL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PRADER-WILLI SYNDROME; YOUNG ADULT;

EID: 78650794846     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2820     Document Type: Article

References (31)

1. Prader A, Labhart A, Willi A. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter [in German]. Schweiz Med Wochen. 1956;86:1260
2. Driscoll DJ, Waters MF, Williams CA, et al. A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes. Genomics. 1992;13(4):917-924
3. Vogels A, Van Den Ende J, Keymolen K, et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet. 2004;12(3):238-240 (Pubitemid 38499983)
4. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38(11):792-798 (Pubitemid 33032939)
5. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91(2):398-402 (Pubitemid 23042323)
6. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108(5). Available at: www.pediatrics.org/cgi/content/full/108/5/e92
7. Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H. Relationship between clinical and genetic diagnosis of Prader-Willi syndrome. J Med Genet. 2002;39(12):926-932 (Pubitemid 36009156)
8. Gallagher RC, Pils B, Albalwi M, Francke U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 2002;71(3):669-678 (Pubitemid 34970140)
9. Sahoo T, del Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008;40(6):719-721 (Pubitemid 351748873)
10. Lupski JR. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 1998;14(10):417-422
11. Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and nondeletion patients with Prader-Willi syndrome. Hum Genet. 1995;96(6):638-643
12. Gunay-Aygun M, Heeger S, Schwartz S, Cassidy SB. Delayed diagnosis in patients with Prader-Willi syndrome due to maternal uniparental disomy 15. Am J Med Genet. 1997;71(1):106-110 (Pubitemid 27276708)
13. Milner KM, Craig EE, Thompson RJ, et al. Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry. 2005;46(10):1089-1096
14. Mitchell J, Schinzel A, Langlois S, et al. Comparison of phenotype in uniparental disomy and deletion Prader-Willi syndrome: sex specific differences. Am J Med Genet. 1996;65(2):133-136
15. Roof E, Stone W, MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res. 2000;44(pt 1):25-30
16. Varela MC, Kok F, Setian N, Kim CA, Koiffmann CP. Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients. Clin Genet. 2005;67(1):47-52
17. Spritz RA, Bailin T, Nicholls RD, et al. Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. Am J Med Genet. 1997;71(1):57-62
18. Wiesner GL, Bendel CM, Olds DP, et al. Hypopigmentation in the Prader-Willi syndrome. Am J Hum Genet. 1987;40(5):431-442
19. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113(3 pt 1):565-573
20. de Lind van Wijngaarden RF, Otten BJ, Festen DA, et al. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(5):1649-1654
21. Stevenson DA, Anaya TM, Clayton-Smith J, et al. Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet A. 2004;124A(2):158-164
22. Carrel AL, Lee PDK, Mogul HR. Growth hormone and Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman BY, eds. Management of Prader-Willi Syndrome. 3rd ed. New York, NY: Springer; 2006:201-244
23. Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D. Early manifestations of Prader-Willi syndrome: influence of growth hormone. J Pediatr Endocrinol Metab. 2001;14(suppl 6):1441-1444
24. Lin HY, Lin SP, Lin CC, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol. 2007;42(10):881-887
25. American Academy of Pediatrics, Section on Pediatric Pulmonology. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109(4):704-712
26. Lindgren AC, Hellström LG, Ritzén EM, Milerad J. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr. 1999;158(11):936-940
27. Carrel AL, Myers SE, Whitman BY, Allen DB. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. J Pediatr Endocrinol Metab. 2001;14(8):1097-1105
28. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003;88(5):2206-2212
29. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 2002;87(4):1581-1585
30. Whitman BY, Myers S, Carrel A, Allen D. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Pediatrics. 2002;109(2). Available at: www.pediatrics.org/cgi/content/full/109/2/e35
31. Höybye C, Thorén M. Somatropin therapy in adults with Prader-Willi syndrome. Treat Endocrinol. 2004;3(3):153-160